Taking tirzepatide while pregnant: what the evidence says

You've just found out you're pregnant, and the pen is in the fridge

This happens. A person discovers they are pregnant mid-treatment, looks at the pen sitting in the fridge door, and needs a clear answer before they do anything else. Here it is: stop taking tirzepatide and call your GP or prescriber today. You do not need to wait for symptoms, side effects, or a scheduled clinical review. The decision is not a clinical grey area.

Tirzepatide is not licensed for use in pregnancy. The prescribing information and NHS guidance are explicit: the medicine should not be used during pregnancy or while breastfeeding. Animal reproductive studies have shown adverse effects on foetal development at doses relevant to human treatment, and because controlled human pregnancy data are currently very limited, the precautionary position is firm. The NHS page on tirzepatide confirms this directly, as does the guidance on taking Mounjaro while pregnant, which covers the same medicine under its brand name. For a fuller explanation of why the restrictions exist and what they mean in practice, the page on Mounjaro while pregnant sets out the safety evidence and what to expect after stopping.

What happens next is a conversation with your maternity team and GP, not a decision to make alone. They will advise on how your weight management continues safely during pregnancy through dietary and lifestyle support, and they will monitor you appropriately. The weight you were managing before pregnancy does not disappear as a concern, it just needs a different approach for the duration.

Why the contraception advice matters before you reach that point

One reason people end up pregnant on tirzepatide is that the medicine can reduce the effectiveness of the oral contraceptive pill. This is not a theoretical concern. NHS guidance (reflected on the NHS England weight-management injections page) specifically advises that women taking oral contraceptives should use an additional non-oral method of contraception for the first four weeks of tirzepatide treatment, and for four weeks after every dose increase. The mechanism is gastric slowing: tirzepatide delays stomach emptying, which can reduce absorption of an oral pill taken during those windows.

No equivalent recommendation currently exists for semaglutide (Wegovy), but the tirzepatide guidance is clear. If you started Mounjaro without knowing this, you are not alone, a question our prescribers field regularly is whether the pill is still reliable on this treatment. The short answer is: not reliably during the windows described, which is why the additional method matters. For more detail on the overlap between fertility and this medicine, the page on getting pregnant on tirzepatide covers the evidence in full.

If you are planning a pregnancy rather than already in one, the conversation to have is with your prescriber before you stop contraception. Timing the wash-out period correctly is something a clinician should advise on individually, it is not something to calculate from a general article.

Planning to conceive: the wash-out question

The MHRA advises using contraception while on GLP-1 medicines and for a defined wash-out period before trying to conceive. The exact timing for tirzepatide specifically should come from your prescriber or GP, who can factor in your dose history, your overall health, and any other medicines you take. Stopping tirzepatide early without a plan for managing your weight in the interim is also worth discussing, sudden appetite changes after stopping can be significant, and your clinical team can help you bridge that period sensibly.

The NHS tirzepatide medicines page covers the key safety information including pregnancy and contraception, and is a reliable starting point before your GP appointment. The page on being pregnant on tirzepatide addresses scenarios where conception has already occurred. For the broader picture of how this treatment works and who it is intended for outside of pregnancy, the Mounjaro overview covers the licensed use, trial evidence, and what the clinical assessment at a service like ours involves. If you have other questions about the medicine's interactions with daily life, you may also find the guidance on drinking alcohol on Mounjaro useful once the immediate concern here is resolved.

If you are not currently pregnant and are considering tirzepatide for weight management, start your free consultation and a GPhC-registered prescriber will review your suitability the same day, including any questions about contraception, reproductive planning, or timing.